Company / Current Liabilities
Viking Therapeutics, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$76.7M
FY2025
5-year range
$8.8M / $76.7M
FY2021-FY2025
Trend
+179.7%
vs FY2024
Sector context
#117 of 213
Health Care
What the data says
At $77M, Viking Therapeutics, Inc.'s current liabilities ranks #97 of 213 in the Health Care sector. Current Liabilities has fluctuated over the past 10 years, ranging from $5M in FY2018 to $77M in FY2025.
Based on SEC 10-K filings.
$77M in FY2025 with a 5-year CAGR of +44.6%.
Increased from $19M to $77M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +51.7%
- 5-Year CAGR
- +44.6%
- 10-Year CAGR
- -
Sector benchmark
#97 of 213 in Health CareTop 45% of 213This company $76.7M Sector average $1.6B
▼
-95.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +44.6%, indicating consistent growth.
- In FY2025, current liabilities increased 179.7% year-over-year.
- Ranks #117 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $76.7M | +179.7% |
| FY2024 | $27.4M | +43.3% |
| FY2023 | $19.1M | -12.8% |
| FY2022 | $21.9M | +150.0% |
| FY2021 | $8.8M | -27.6% |
| FY2020 | $12.1M | +79.0% |
| FY2019 | $6.8M | +48.9% |
| FY2018 | $4.5M | -47.4% |
| FY2017 | $8.7M | +33.7% |
| FY2016 | $6.5M | +227.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026